Life ScienceCompany
Mayne Pharma M&A Summary
Mayne Pharma has acquired 4 companies of its own. It has also divested 2 assets.
Mayne Pharma’s largest acquisition to date was in 2012, when it acquired Metrics for $120M. It’s largest disclosed sale occurred in 2022, when it sold Metrics Contract Services to Catalent for $475M. Mayne Pharma has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).
Mayne Pharma Ownership
Who owns Mayne Pharma?
Mayne Pharma is owned by Cosette Pharmaceuticals. It was acquired on February 20, 2025.
Mayne Pharma Business Overview
Where is Mayne Pharma headquartered?
Mayne Pharma is headquartered in Salisbury South, Australia.
What is Mayne Pharma’s revenue?
Mayne Pharma disclosed revenue of 388M AUD for 2024 and 182M AUD for 2023.
What sector is Mayne Pharma in?
Mayne Pharma is a life science company.
M&A Summary
-
M&A Total Activity6
- M&A Buy Activity4
- M&A Sell Activity2
- Total Sectors Invested 1
- Total Countries Invested 2
- M&A Buy/Sell Connections 3
Unlimited Searches
